Review of the Prevention of the Hepatitis B Virus Infection Transmission From Mother to Child During Pregnancy

Context: The hepatitis B virus (HBV) is a highly infectious virus which spreads through blood and other infected fluids such as semen. Individuals can be infected with the virus through sexual contact, by sharing needles or by a needle accident, by getting a body piercing or tattooing, and prenatally or at birth, if the mother is infected with the virus. Evidence Acquisition: We searched medical databases (namely PubMed and Scopus) from January 2000 to January 2015. Keywords were epidemiology, transmission routes, and prevention of infection during pregnancy. Results: On the basis of our results, the transmission of the HBV from the infected mother to her child during pregnancy is an important way for the acquisition of the virus. The routine vaccination of neonates and the use of immunoglobulin at birth are very effective for the prevention of infection, when a mother is infected. Also, the treatment of the infected mother to decrease the viral load is another preventive method for the protection of her child. Conclusions: Our study showed that routine vaccination in children and screening of pregnant women for the HBV infection and then preventative strategies for neonates are the most important routes for minimizing the transmission of infection from mother to child.

[1]  Guohong Deng,et al.  Telbivudine prevents vertical transmission of hepatitis B virus from women with high viral loads: a prospective long-term study. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  C. Thio,et al.  Breastfeeding while taking lamivudine or tenofovir disoproxil fumarate: a review of the evidence. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  Pei Liu,et al.  Immunization interventions to interrupt hepatitis B virus mother-to-child transmission: a meta-analysis of randomized controlled trials , 2014, BMC Pediatrics.

[4]  V. Jackson,et al.  Lamivudine treatment and outcome in pregnant women with high hepatitis B viral loads , 2014, European Journal of Clinical Microbiology & Infectious Diseases.

[5]  Noele P. Nelson,et al.  Prevention of Perinatal Hepatitis B Virus Transmission. , 2014, Journal of the Pediatric Infectious Diseases Society.

[6]  Hua Zhang,et al.  Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice , 2014, Hepatology.

[7]  A. Chang,et al.  Use of Tenofovir Disoproxil Fumarate in Highly Viremic, Hepatitis B Mono-Infected Pregnant Women , 2014, Digestive Diseases and Sciences.

[8]  S. Locarnini,et al.  Anti‐viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post‐partum flare , 2014, Alimentary pharmacology & therapeutics.

[9]  N. Montenegro,et al.  Prevention of mother-to-child transmission: experience of a Portuguese centre , 2014, Journal of the International AIDS Society.

[10]  M. Dal,et al.  Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection. , 2013, World journal of gastroenterology.

[11]  H. Hsu,et al.  Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention. , 2013, Journal of hepatology.

[12]  A. Riyaz,et al.  Prevention of mother to child transmission of hepatitis B infection , 2013, Indian Pediatrics.

[13]  H. Poustchi,et al.  Seroprevalence of Hepatitis B Surface Antigen and Anti Hepatitis C Antibody in Zahedan City, Iran: A Population-Based Study , 2012, Hepatitis monthly.

[14]  H. Hsu,et al.  Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. , 2012, Gastroenterology.

[15]  J. Sasadeusz,et al.  Antiviral Therapy for Hepatitis B Infection during Pregnancy and Breastfeeding , 2011, Antiviral therapy.

[16]  Rita Singh,et al.  Seroprevalence of hepatitis B infection during pregnancy and risk of perinatal transmission , 2011, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[17]  Huy Trinh,et al.  Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B. , 2011, Gastroenterology.

[18]  Xiaomao Li,et al.  Lamivudine in Late Pregnancy to Interrupt In Utero Transmission of Hepatitis B Virus: A Systematic Review and Meta-Analysis , 2010, Obstetrics and gynecology.

[19]  Xiaomao Li,et al.  Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission-a meta-analysis. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[20]  Fanz Zhang,et al.  Gaps in Hospital Policies and Practices to Prevent Perinatal Transmission of Hepatitis B Virus , 2010, Pediatrics.

[21]  Hung‐Chih Yang,et al.  Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double‐blind, placebo‐controlled study , 2009, Journal of viral hepatitis.

[22]  Huy Trinh,et al.  Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. , 2008, The New England journal of medicine.

[23]  Alavian SeyedMoayed,et al.  Hepatitis B Virus Infection in Iran: A Systematic Review , 2008 .

[24]  E. Overton,et al.  Adverse Effects of Tenofovir Use in HIV-infected Pregnant Women and their Infants , 2008, The Annals of pharmacotherapy.

[25]  S. Zeichner,et al.  Decreased bone mineral density with off-label use of tenofovir in children and adolescents infected with human immunodeficiency virus. , 2008, The Journal of pediatrics.

[26]  B. Sharifi-Mood,et al.  Hepatitis B and C virus infections in patients with hemophilia in Zahedan, southeast Iran. , 2007, Saudi medical journal.

[27]  S. Zeichner,et al.  Tenofovir Disoproxil Fumarate and an Optimized Background Regimen of Antiretroviral Agents as Salvage Therapy: Impact on Bone Mineral Density in HIV-Infected Children , 2006, Pediatrics.

[28]  M. Salehi,et al.  Spectrum of clinical disease in a series of hospitalized HIV-infected patients from southeast of Iran. , 2006, Saudi medical journal.

[29]  B. Sharifi-Mood,et al.  Comparison of Prevalence of Hepatitis B Virus Infection in Non Official Barbers with Blood Donors , 2006 .

[30]  H. Margolis,et al.  A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. , 2005, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[31]  M. Salehi,et al.  Prevalence of Hepatitis B Surface Antigen in Pregnant Women in Zahedan, Iran , 2004 .

[32]  D. Lavanchy,et al.  Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures , 2004, Journal of viral hepatitis.

[33]  S. Ranger-Rogez,et al.  Hepatitis B mother-to-child transmission , 2004, Expert review of anti-infective therapy.

[34]  A. Tarantal,et al.  Fetal and Maternal Outcome After Administration of Tenofovir to Gravid Rhesus Monkeys (Macaca mulatta) , 2002, Journal of acquired immune deficiency syndromes.

[35]  M. Azam,et al.  Detection of hepatitis B surface antigen in pregnant women attending a public hospital for delivery: implication for vaccination strategy in Bangladesh. , 1998, The American journal of tropical medicine and hygiene.

[36]  Y. Poovorawan,et al.  Long term efficacy of hepatitis B vaccine in infants born to hepatitis B e antigen-positive mothers. , 1992, The Pediatric infectious disease journal.